CytoDyn reached enrollment target of 293 patients for 2nd DSMC interim analysis of phase 3 COVID-19 trial
On Nov. 23, 2020, CytoDyn announced it had reached enrollment of 293 patients in its Phase 3 trial…
-
-
Fred Hutch began experimental COVID-19 vaccine efficacy trial
On Nov. 9, 2020, the Fred Hutchinson Cancer Research Center announced the start of volunteer enrollment for a…
-
Kaiser Permanente Research Institute enrolled volunteers in a phase 3 clinical trial to evaluate COVID-19 vaccine
On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase…
-
HHS and DOD announced $12.7 million contract with InBios to boost US production of rapid COVID-19 tests
On Oct. 30, 2020, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of…
-
Seagen announced closing of $1.0 billion stock sale to Merck
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
-
Just – Evotec Biologics received grant to enable an antibody product for the prevention of COVID-19
On Oct. 19, 2020, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics had received a grant…
-
Fred Hutch completed move-in of Lake Union Steam Plant
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
-
Fred Hutch opened COVID-19 clinical research center
On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…
-
Biotechnology | NIH | Vaccine
COVID-19 vaccine generated immune response in older adults
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…
-
Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the NIH announed that researchers had designed ﾓminiproteinsﾔ that bound tightly to the SARS-CoV-2…
-
Pascal Biosciences confirmed specific cannabinoids combat Coronavirus
On Sept. 23, 2020, Pascal Biosciences announced the Company had confirmed an earlier report that certain cannabinoids block…
-
University of Washington blood test detected past infections with new coronavirus
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
-
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
-
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
-
Just – Evotec Biologics initiated construction of first JPOD Facility in North America
On Jan. 14, 2020, Evotec announced that the wholly-owned Seattle based company Just – Evotec Biologics had initiated…
-
Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
-
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
-
Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
-
Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
-
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
-
Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
-
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
-
Celgene acquired Juno Therapeutics for $9 billion
On Jan. 22, 2018, Celgene and Juno Therapeutics announced the signing of a merger agreement in which Celgene…
-
Costco co-founder Jeff Brotman and Dan Baty donated $50 million to create the Brotman Baty Institute for Precision Medicine
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
-
Biotechnology | Environmental | Genomics | Life Science History | Medicine | Non-Profit Research | Pharmaceutical
Earth Microbiome Project scientists announced unprecedented catalog of microbial life on planet Earth
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
-
Paul G Allen Frontiers Group announced two new Allen Discovery Centers
On Oct. 11, 2017, the Paul G. Allen Frontiers Group announced the creation of two new Allen Discovery…
-
The Bill & Melinda Gates Foundation pledged $279 million to University of Washington’s Institute for Health Metrics and Evaluation
On Jan. 25, 2017, the Bill & Melinda Gates Foundation pledged $279 million to the University of Washington’s…
-
University of Washington Population Health Initiative received $210 million transformative gift from the Gates Foundation
On Oct. 25, 2016, the University of Washington’s Population Health Initiative received a $210 million gift from the…
-
Washington Life Science Evolution, 2015
Washington Life Science Evolution illustrates life science companies and non-profit research organizations located in the State of Washington…
-
Washington Life Science History
Washington Life Science History is a poster that illustrates significant events in the development of the life science…
